BiotechTube
Home/Racura Oncology/Dr Peter Smith
DP

Dr Peter Smith

Executive Chair

Racura Oncology

Therapeutic Areas

Oncology

Racura Oncology Pipeline

DrugIndicationPhase
RC220Acute Myeloid Leukaemia (AML)Phase 3

Leadership Team at Racura Oncology

DS
Dr Serge Scrofani
Independent Non‑Executive Director
DM
Dr Megan Baldwin
Independent Non‑Executive Director
View full Racura Oncology profile